Philips and Masimo have renewed a longstanding strategic partnership to develop patient care solutions.
This time, the companies stated that their collaboration would primarily focus on advancing patient access to monitoring and measurement technologies, with more integrated tools that support “better outcomes across the continuum of care”.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
A core aspect of the companies’ plans will be in integrating Masimo’s sensor technologies, SET pulse oximetry, and Radius PPG tools into Philips’ multi-parameter patient monitoring platforms.
According to the companies, the planned integrations will provide clinicians with reliable data and insights across bedside monitors, central stations, and wearable solutions. The resulting technology is slated to enhance interoperability and support continuity of patient care.
Masimo’s CEO Katie Szyman commented: “Expanding our strong, long-standing partnership with Philips allows us to build on our shared legacies of innovation and helps ensure that Masimo’s best-in-class technologies reach even more patients.”
With the development of this unified foundation, the companies also plan to collaborate on next-generation monitoring solutions they state reflect emerging clinical needs and evolving market demand such as the need for greater patient mobility.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataJulia Strandberg, executive vice president and business leader of connected care at Philips commented: “Our priority is helping clinicians deliver the best possible care to their patients, and that means staying ahead of the curve.”
In July, Philips renewed a similar relationship with Medtronic to help realise what Philips’ general manager of clinical applications and devices for hospital patient monitoring, Sachin Chaudhari, referred to as a “more comprehensive” patient monitoring solution.
Medtronic itself recently signed a similar partnership with the Manchester University UK National Health Service (NHS) Foundation Trust (MFT) to co-develop healthcare technologies, including a remote monitoring pathway named TriageHP Plus. According to GlobalData analysis, the global remote patient monitoring market is forecast to grow by a CAGR of 2.1% to reach a valuation of almost $26bn by 2034, up from $20.9bn in 2024.
